Latest News for: autoimmune
Edit
JJP Biologics Reports Positive Top‑Line Phase I Data for JJP‑1212, Validating Innovation in Autoimmune Therapy
GetNews 22 Jan 2026
JJP Biologics reports positive Phase I results for JJP‑1212, a first-in-class anti-CD89 antagonist, showing safety and promising efficacy in autoimmune and inflammatory diseases.
Edit
J&J’s Sales and Profit Rise on Strong Cancer and Autoimmune Drug Sales
Wall Street Journal 21 Jan 2026
The healthcare company’s forecast for 2026 tops Wall Street’s expectations ... .
Edit
Citizen Tribune
20 Jan 2026
Ouro Medicines Receives U.S. FDA Fast Track Designation for Gamgertamig in Immune Thrombocytopenia and Autoimmune ...
Citizen Tribune
20 Jan 2026
Gamgertamig previously received Orphan Drug Designation (ODD) for development in immune thrombocytopenia and autoimmune hemolytic anemia ....
Edit
Ouro Medicines Receives U.S. FDA Fast Track Designation for Gamgertamig in Immune Thrombocytopenia and Autoimmune Hemolytic Anemia
PR Newswire 20 Jan 2026
Gamgertamig previously received Orphan Drug Designation (ODD) for development in immune thrombocytopenia and autoimmune hemolytic anemia ... About Autoimmune Cytopenias. Autoimmune cytopenias are diseases ...
Edit
Autoimmune Encephalitis Market Size in the 7MM is expected to grow at a significant CAGR ...
GetNews 15 Jan 2026
Autoimmune Encephalitis Epidemiology Segmentation in the 7MM Autoimmune Encephalitis Prevalent cases Autoimmune Encephalitis Type- specific cases Autoimmune Encephalitis Age-specific cases Autoimmune ...
Edit
Independent Record
13 Jan 2026
10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease
Independent Record
13 Jan 2026
Edit
“Absolute Healing” on BrightU: How to reverse cancer, autoimmunity and lung disease by healing the ...
Natural News 13 Jan 2026
Edit
Evaxion expands AI-Immunology™ platform into autoimmune diseases
Nasdaq Globe Newswire 13 Jan 2026
... platform to also discover and develop new treatments for autoimmune diseases.
Edit
Evaxion expands AI-Immunology platform into autoimmune diseases (Form 6-K) (Evaxion A/S)
Public Technologies 13 Jan 2026
Evaxion expands AI-Immunology™ platform into autoimmune diseases Evaxion adds autoimmune disease as a third disease area as it expands its therapeutic focus In future, Evaxion's proprietary ...
Edit
EXPANDING CDMP COVERAGE TO INCLUDE HIGH-BURDEN AUTOIMMUNE OR MULTISYSTEM CONDITIONS (Ministry of Health of the Republic of Singapore)
Public Technologies 13 Jan 2026
To ask the Coordinating Minister for Social Policies and Minister for Health (a) what clinical, epidemiological, or cost-effectiveness considerations have precluded autoimmune or multisystem ...
Edit
Immuthera Announces Global Exclusive License from City of Hope for First-in-Class CD6/CTLA-4 CAR-Treg Platform for Autoimmune and Inflammatory Diseases
Pharmiweb 13 Jan 2026
Global exclusivity for Type 1 Diabetes, Rheumatoid Arthritis, 8 Dermatological Autoimmune diseases, and 13 Neuroinflammatory Autoimmune diseases ... unmet needs in inflammatory and autoimmune diseases.
Edit
Nurix Therapeutics Outlines 2026 Goals and Objectives for Advancing Bexobrutideg and Its Pipeline of Novel Degrader-Based Medicines in Cancer and Autoimmune Diseases (Nurix Therapeutics Inc)
Public Technologies 12 Jan 2026
Expand bexobrutideg into autoimmune and inflammatory indications, targeting IND submission in 2026 with a new tablet formulation ... Advancing Pipeline in Inflammation and Autoimmune Diseases Introduced ...
- 1
- 2
- Next page »
